Sarah Davis

Sarah Davis (she/her) (22Ox) is from Austin, Texas, majoring in politics, philosophy, law and English. Outside of the Wheel, she runs for the Oxford Cross Country team and is the president of Bread Oxford. On a typical day, you can find her reading on the Oxford quad in her hammock.

EPD Chief aims to continue “victim-centered” approach to policing

A member of Emory Police Department (EPD) for 23 years, EPD Chief Cheryl Elliott has long committed to Emory University law enforcement. Even after her retirement from deputy chief in 2017, Elliott took on a consulting role from 2017-2019, during which she developed EPD’s Policy Manual.  Two years later, Elliott rejoined the department as police [...]

Read More

Emory will move to yellow operating status

Emory University will return to a yellow operating status on Jan. 31, according to a Tuesday email announcement from Associate Vice President and Executive Director for COVID-19 Response and Recovery Amir St. Clair. Campus operated at a “modified” yellow operating status for almost all of the fall semester.  “The yellow operating condition will help limit [...]

Read More

The 21 Stories that Shaped 2021

Click below for interactive view From Emory University’s mass vaccination effort against COVID-19 to a gold medal performance from former Emory swimmer Andrew Wilson (17C) at the Tokyo Olympics, 2021 held tremendous victories for the Emory community. However, the year also presented great tragedy. With the Atlanta spa shootings devastating the metro area’s Asian American [...]

Read More

Emory to hold spring courses remotely for first three weeks

Emory University will conduct spring semester courses remotely for the first three weeks of school due to the rising cases of the Omicron variant, according to a Dec. 28 email from University President Gregory L. Fenves to the Emory community.  The campus, including residence halls, will open as planned on Jan. 4 and students are [...]

Read More

FDA authorizes COVID-19 oral antiviral developed at Emory

The U.S. Food and Drug Administration (FDA) authorized molnupiravir, an antiviral pill, for COVID-19 treatment in an Emergency Use Authorization (EUA) on Dec. 23. The pill, which was submitted for FDA authorization by Merck and Ridgeback Biotherapeutics on Oct. 11, was discovered by Drug Innovation Ventures at Emory (DRIVE) scientists, led by CEO George Painter. [...]

Read More